Download PDF
Drug Res (Stuttg) 2024; 74(02): e1
DOI: 10.1055/a-2235-8845
Erratum

Correction: Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of Cancer

Alireza Poustforoosh
1   Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
,
Sanaz Faramarz
2   Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran
,
Mohammad Hadi Nematollahi 
2   Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran
3   Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
,
Mehdi Mahmoodi
2   Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran
,
Mahdiyeh Azadpour
4   Department of Chemical Engineering, Faculty of Engineering, Shahid Bahonar University of Kerman, Kerman, Iran
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Correction to:

Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of CancerDrug Res (Stuttg) 2024; 74(02): 81-88
DOI: 10.1055/a-2211-2218

Erratum

Alireza Poustforoosh, Sanaz Faramarz, Mohammad Hadi Nematollahi et al. Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of Cancer. Drug Research 2023

10.1055/a-2211-2218

In the above mentioned article two references have been added.

2 Paydar P, Asadikaram G, Nejad HZ, et al. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors. Journal of Cellular Biochemistry 2019; 120: 13726-13736

3 Wang C-Q, Tang C-H, Tzeng H-E et al. Impacts of RETN genetic polymorphism on breast cancer development. Journal of Cancer 2020; 11: 2769



Publication History

Article published online:
11 January 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany